Clinical Trial Update: Comparison of Low Dose Versus High Dose Cyclophosphamide as Induction Therapy in the Treatment of Lupus Nephritis [Phase 4]

View source ↗

Summary

This Phase 4 trial compared low-dose versus high-dose cyclophosphamide as induction therapy for lupus nephritis and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• Cytoxan (cyclophosphamide)

Snippet

Sponsor: Jawaharlal Institute of Postgraduate Medical Education & Research | Conditions: Lupus Nephritis | Phase 4 | Status: COMPLETED